PriceTargets.com logo

Primary Health Properties - PHP Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 107.50
  • Forecasted Upside: 12.80%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
GBX 95.30 As of 03/25/2025 01:42 PM ET
▲ +0.05 (0.05%)

This chart shows the closing price for PHP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
JanFebMar95.30Closing price on 03/25/25:
Get New Primary Health Properties Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PHP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PHP

Analyst Price Target is GBX 107.50
▲ +12.80% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Primary Health Properties in the last 3 months. The average price target is GBX 107.50, with a high forecast of GBX 110 and a low forecast of GBX 105. The average price target represents a 12.80% upside from the last price of GBX 95.30.

This chart shows the closing price for PHP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
3/246/249/2412/243/254/2660738699113Closing price on 03/25/25: 95.30High110.00Average107.50Low105.00




Current Consensus is Buy

The current consensus among 3 contributing investment analysts is to buy stock in Primary Health Properties. This rating changed within the last month from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
10/2/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
12/31/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
3/30/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/28/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/26/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/25/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
2/23/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2025

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/3/2025Jefferies Financial GroupReiterated RatingBuyGBX 105
10/16/2024Shore CapitalReiterated RatingBuy
9/18/2024Berenberg BankBoost TargetBuyGBX 103 ➝ GBX 110
8/5/2024Berenberg BankReiterated RatingBuyGBX 103
7/24/2024Shore CapitalReiterated RatingBuy
3/1/2024JPMorgan Chase & Co.Initiated CoverageNeutralGBX 105
2/9/2024Berenberg BankReiterated RatingBuyGBX 103
5/25/2023BarclaysLower TargetUnderweightGBX 100 ➝ GBX 98
2/27/2023Berenberg BankLower TargetHoldGBX 165 ➝ GBX 125
12/1/2022BarclaysDowngradeUnderweightGBX 150 ➝ GBX 105
8/31/2022Berenberg BankLower TargetHoldGBX 170 ➝ GBX 165
7/4/2022BarclaysLower TargetOverweightGBX 160 ➝ GBX 140
5/23/2022BarclaysReiterated RatingOverweightGBX 160
5/6/2022BarclaysReiterated RatingOverweightGBX 160
4/19/2022BarclaysReiterated RatingOverweightGBX 160
4/1/2022BarclaysReiterated RatingOverweightGBX 160
3/31/2022Berenberg BankReiterated RatingHoldGBX 170
3/21/2022BarclaysReiterated RatingOverweightGBX 160
3/8/2022BarclaysReiterated RatingOverweightGBX 156
2/15/2022BarclaysReiterated RatingOverweightGBX 164
2/11/2022Peel HuntReiterated RatingBuyGBX 175
2/3/2022BarclaysReiterated RatingOverweightGBX 164
1/24/2022BarclaysReiterated RatingOverweightGBX 164
12/8/2021Liberum CapitalReiterated RatingHoldGBX 176
11/24/2021Liberum CapitalReiterated RatingHold
10/29/2021BarclaysReiterated RatingOverweightGBX 164
10/28/2021Peel HuntReiterated RatingBuyGBX 175
10/28/2021Peel HuntReiterated RatingBuyGBX 175
8/4/2021Berenberg BankBoost TargetHoldGBX 160 ➝ GBX 170
8/3/2021Liberum CapitalDowngradeHoldGBX 170 ➝ GBX 176
7/28/2021Liberum CapitalReiterated RatingBuyGBX 170
5/12/2021Numis SecuritiesReiterated RatingAddGBX 184
5/12/2021Liberum CapitalReiterated RatingBuy
2/17/2021Jefferies Financial GroupBoost TargetBuyGBX 168 ➝ GBX 172
7/29/2020Peel HuntReiterated RatingAdd
7/29/2020Liberum CapitalReiterated RatingBuy
7/14/2020Berenberg BankDowngradeHoldGBX 150 ➝ GBX 155
7/9/2020Liberum CapitalReiterated RatingBuy
7/9/2020Peel HuntReiterated RatingRestricted
5/28/2020Peel HuntReiterated RatingAdd
5/11/2020Liberum CapitalReiterated RatingBuy
5/6/2020Berenberg BankReiterated RatingBuy
5/6/2020Peel HuntBoost TargetAddGBX 160 ➝ GBX 175
4/15/2020Peel HuntReiterated RatingAdd
4/15/2020BarclaysReiterated RatingOverweightGBX 168 ➝ GBX 170
4/2/2020Jefferies Financial GroupUpgradeBuyGBX 165 ➝ GBX 179
4/1/2020Peel HuntReiterated RatingAdd
4/1/2020Liberum CapitalReiterated RatingBuy
3/25/2020Berenberg BankUpgradeBuy
(Data available from 3/25/2020 forward)

News Sentiment Rating

0.71 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
8/27/2024
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/26/2024
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/26/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/25/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/25/2024
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
1/24/2025
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/23/2025
  • 7 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/25/2025

Current Sentiment

  • 7 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Primary Health Properties logo
Primary Health Properties plc is a leading investor in modern primary healthcare properties. The Company acquires or forward funds the development of modern, purpose-built premises that are leased to GP's, government healthcare bodies, pharmacies and other providers of related healthcare services.
Read More

Today's Range

Now: GBX 95.30
Low: 95.10
High: 96.25

50 Day Range

MA: GBX 92.42
Low: 88.55
High: 96.90

52 Week Range

Now: GBX 95.30
Low: 85.40
High: 105.50

Volume

98,248,672 shs

Average Volume

9,447,610 shs

Market Capitalization

£1.28 billion

P/E Ratio

N/A

Dividend Yield

7.68%

Beta

0.41

Frequently Asked Questions

What sell-side analysts currently cover shares of Primary Health Properties?

The following Wall Street analysts have issued research reports on Primary Health Properties in the last year: Berenberg Bank, Jefferies Financial Group Inc., and Shore Capital.
View the latest analyst ratings for PHP.

What is the current price target for Primary Health Properties?

0 Wall Street analysts have set twelve-month price targets for Primary Health Properties in the last year. Their average twelve-month price target is GBX 107.50, suggesting a possible upside of 12.8%. Berenberg Bank has the highest price target set, predicting PHP will reach GBX 110 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of GBX 105 for Primary Health Properties in the next year.
View the latest price targets for PHP.

What is the current consensus analyst rating for Primary Health Properties?

Primary Health Properties currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PHP will outperform the market and that investors should add to their positions of Primary Health Properties.
View the latest ratings for PHP.

What other companies compete with Primary Health Properties?

Other companies that are similar to Primary Health Properties include Assura, Target Healthcare REIT, Impact Healthcare REIT, Life Science REIT and Medicx Fund. Learn More about companies similar to Primary Health Properties.

How do I contact Primary Health Properties' investor relations team?

Primary Health Properties' physical mailing address is 5th Fl, Greener House, 66-68 Haymarket, LONDON, SW1Y 4RF, United Kingdom. The real estate investment trust's listed phone number is +44-20-71045599. The official website for Primary Health Properties is www.phpgroup.co.uk. Learn More about contacing Primary Health Properties investor relations.





Receive Primary Health Properties News & Ratings Daily
Sign up to receive the latest news and ratings for Primary Health Properties and its competitors with PriceTargets.com’s free daily newsletter.